Cargando…

Patient-Derived Cancer Organoids for Precision Oncology Treatment

The emergence of three-dimensional human organoids has opened the door for the development of patient-derived cancer organoid (PDO) models, which closely recapitulate parental tumor tissue. The mainstays of preclinical cancer modeling include in vitro cell lines and patient-derived xenografts, but t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pernik, Mark N., Bird, Cylaina E., Traylor, Jeffrey I., Shi, Diana D., Richardson, Timothy E., McBrayer, Samuel K., Abdullah, Kalil G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8156513/ https://www.ncbi.nlm.nih.gov/pubmed/34067714 http://dx.doi.org/10.3390/jpm11050423

Ejemplares similares

Contemporary Mouse Models in Glioma Research
por: Hicks, William H., et al.
Publicado: (2021)

Molecular and Metabolic Mechanisms Underlying Selective 5-Aminolevulinic Acid-Induced Fluorescence in Gliomas
por: Traylor, Jeffrey I., et al.
Publicado: (2021)

Semi-Automated Computational Assessment of Cancer Organoid Viability Using Rapid Live-Cell Microscopy
por: Buehler, Joseph D, et al.
Publicado: (2022)

Establishment of patient-derived organoid models of lower-grade glioma
por: Abdullah, Kalil G, et al.
Publicado: (2021)

Surgical Management of a Massive Frontal Bone Hemangioma: Case Report
por: Bird, Cylaina E., et al.
Publicado: (2022)

Primary peripheral T-cell central nervous system lymphoma
por: Bird, Cylaina E., et al.
Publicado: (2021)

Organoids as an Enabler of Precision Immuno-Oncology
por: Zhao, Junzhe, et al.
Publicado: (2023)

A human breast cancer-derived xenograft and organoid platform for drug discovery and precision oncology
por: Guillen, Katrin P., et al.
Publicado: (2022)

The promises and challenges of patient‐derived tumor organoids in drug development and precision oncology
por: Granat, Lauren M., et al.
Publicado: (2019)

Preclinical modeling of lower-grade gliomas
por: Tang, Lilly W., et al.
Publicado: (2023)

A Quantitative Analysis of Social Media to Determine Trends in Brain Tumor Care and Treatment
por: Bird, Cylaina E, et al.
Publicado: (2020)

Correction: A Quantitative Analysis of Social Media to Determine Trends in Brain Tumor Care and Treatment
por: Bird, Cylaina E, et al.
Publicado: (2021)

Integration of Genomic Profiling and Organoid Development in Precision Oncology
por: Yoon, Hyunho, et al.
Publicado: (2021)

Patient-derived organoids for precision oncology: a platform to facilitate clinical decision making
por: Chitrangi, Swati, et al.
Publicado: (2023)

Correction: Patient-derived organoids for precision oncology: a platform to facilitate clinical decision making
por: Chitrangi, Swati, et al.
Publicado: (2023)

Chromosomal instability in adult-type diffuse gliomas
por: Richardson, Timothy E., et al.
Publicado: (2022)

Human plasma-like medium facilitates metabolic tracing and enables upregulation of immune signaling pathways in glioblastoma explants
por: El Shami, Mohamad, et al.
Publicado: (2023)

Immunotherapy for Chordoma and Chondrosarcoma: Current Evidence
por: Traylor, Jeffrey I., et al.
Publicado: (2021)

Patient-Derived Organoids in Precision Medicine: Drug Screening, Organoid-on-a-Chip and Living Organoid Biobank
por: Zhou, Zilong, et al.
Publicado: (2021)

Patient-derived organoids and orthotopic xenografts of primary and recurrent gliomas represent relevant patient avatars for precision oncology
por: Golebiewska, Anna, et al.
Publicado: (2020)

iPSC-Derived Organoids as Therapeutic Models in Regenerative Medicine and Oncology
por: Turhan, Ali G., et al.
Publicado: (2021)

Organoids in Translational Oncology
por: Tatullo, Marco, et al.
Publicado: (2020)

Global DNA methylation profiling reveals chromosomal instability in IDH-mutant astrocytomas
por: Liu, Yan, et al.
Publicado: (2022)

Mismatch repair protein mutations in isocitrate dehydrogenase (IDH)-mutant astrocytoma and IDH-wild-type glioblastoma
por: Richardson, Timothy E, et al.
Publicado: (2023)

New approaches to model glioblastoma in vitro using brain organoids: implications for precision oncology
por: Gomez, Guillermo A., et al.
Publicado: (2019)

Isocitrate dehydrogenase mutations in gliomas: A review of current understanding and trials
por: Sharma, Nikhil, et al.
Publicado: (2023)

Patient derived organoids in prostate cancer: improving therapeutic efficacy in precision medicine
por: Pamarthy, Sahithi, et al.
Publicado: (2021)

Preclinical investigation of patient-derived cervical cancer organoids for precision medicine
por: Seol, Hyang Sook, et al.
Publicado: (2022)

The potential of patient-derived organoids in precision medicine of biliary tract cancer
por: Yáñez-Bartolomé, Mariana, et al.
Publicado: (2023)

Circulating tumor cells in precision oncology: clinical applications in liquid biopsy and 3D organoid model
por: Yang, Chang, et al.
Publicado: (2019)

Organoid modeling for cancer precision medicine
por: Cantrell, Michael A, et al.
Publicado: (2015)

Organoid Models for Precision Cancer Immunotherapy
por: Sun, Cai-Ping, et al.
Publicado: (2022)

Patient‐derived organoids as a preclinical platform for precision medicine in colorectal cancer
por: Cho, Young‐Won, et al.
Publicado: (2022)

Breast cancer organoids and their applications for precision cancer immunotherapy
por: Guan, Dandan, et al.
Publicado: (2023)

Global Implementation of Precision Oncology
por: Yam, Clinton, et al.
Publicado: (2021)

Patient-derived xenografts as compatible models for precision oncology
por: Cho, Sung-Yup
Publicado: (2020)

A pancreas tumor derived organoid study: from drug screen to precision medicine
por: Yao, Jia, et al.
Publicado: (2021)

Patient-Derived Tumor Organoids: New Progress and Opportunities to Facilitate Precision Cancer Immunotherapy
por: Wang, Ji, et al.
Publicado: (2022)

Patient-derived tumor organoids as a platform of precision treatment for malignant brain tumors
por: Chen, Chun-Chung, et al.
Publicado: (2022)

Implementing patient derived organoids in functional precision medicine for patients with advanced colorectal cancer
por: Cartry, Jérôme, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6c41es3c2jbju1fngcpilq0jbt